Titel: BioTrends - LifeScience meets Nano - Technology Trends & Practical Applications
Termin: 11.2.2003 bis 14.2.2003
Veranstaltungsort:
Sonnenallee 225
12057 Berlin
Phone: +49 (0)30 / 68 31- 2 25 22
Fax: +49 (0)30 / 68 31- 23 45
Referenten: Dr. Dolores Cahill (Max Planck Institute of Molecular Genetics); Mike Taussig (Head of Technology Research Group, Babraham Institute); Erig Gedig (MSc, CEO, XanTec bioanalytics GmbH); Prof. Dr. Claus-Michael Lehr (Department of Biopharmaceutics and Pharmaceutical Technology, Saarland University); Dr. Klaus Weishaupt (Managing Director, WITEC Wissenschaftliche Instrumente und Technologie GmbH); Dr. Stephan Haubold (Managing Director, Nanosolutions GmbH); Dr. Jörg D. Hoheisel (Division of Functional Genome Analysis, Deutsches Krebsforschungszentrum); Dr. Rainer Hanselmann (Chairman, NanoBioNet e.V.); Dr. Werner Hoheisel (Scientist, Bayer AG); Dr. Sascha General (Scientist Pharmaceutical Development, Schering AG); Dr. Everad Pap (Head of Assay Technologies, Aventis GmbH); Ph.D. Tony Smith (Chief Technology Officer, Solexa Limited); Robert Ellis (Executive Vice President for Research & Development, Affymetrix Inc.); Dr. Bettina Möckl (Sales and Marketing Manager Genomic Services, Qiagen GmbH); Dr. Brian McKeown (Technical Development Manager, Orchid BioScience); Dr. Peter Wagner (Senior Vice President & Chief Technology Officer, Zyomyx Inc.); Dr. Markus Ehrat (CEO, Zeptosens AG); Dr. Gitte Neubauer (Vice President Analytical Siences, Cellzome); Prof. Ulf Landegren (Department of Genetics & Pathology, University of Uppsala); Dr. Bernd Stanislawski (Project Leader Microfluidics, Merck KGaA); Dr. Christoph Gauer (CEO, Advalytix AG); Dr. Carlo Effenhauser (Roche Instrument Center AG); Dr. Holger Bartos (Product Manager Microfluidics, STEAG microParts GmbH); Dr. Per Andersson (Director Applied Research, Gyros AB); Dr. Michael R. Alvers (Director Product Marketing and Product Management, DEFiNiENS AG); Juha Kononen (MD, PhD, Chief Scientific Officer, R&D, Diomeda Life Sciences, Inc.); Dr. Karin Adelhelm (Director Product Support & Marketing, Clondiag); Christine Lemke (COO MelTec GmbH); Dr. Sven Schurierer (Senior Scientist, Life Science Informatics, Novartis Pharma AG); Dr. Klaus Stöckemann (Investment Director, 3i Deutschland Gesellschaft für Industriebeteiligungen mbH); Dr. Robert Harrison (Huber & Schüssler Patent & Trade Mark Attorneys); Dr. Guy Vergnault (Oral Drug Delivery Business Unit Leader, SkyePharma AG); Dr. Eckhard Nordhoff (Director Research & Development, Scienion AG, Berlin); Dr. Johannes Schuchhardt (CSO, MicroDiscovery GmbH)
developments in the area of life sciences covering the latest technological developments and applications in
Nanobiotechnology as well as Biochips and Bioinformatics. These technologies are helping to revolutionize the
pharmaceutical business from R+D to laboratory testing and diagnostics.
Distinguished experts from around the world are brought together by the BioTrends Congress to work on a common
goal - creating the life science roadmap for the future.
Europe contributes to the global advancement in biotechnological research and plays a central part with its leading
scientific institutions and companies.
The BioTrends Congress aims to promote the exchange between international academics, research institutions,
leading industrial corporations and innovative start-up enterprises. It provides the opportunity to share firsthand
experiences, to network and to learn from each other.
Hosting this event in Berlin, the center of Europe, we encourage collaboration between industry and the academic
communities throughout Europe and the rest of the world.
Kontakt:
IIR Deutschland GmbH
P.O.Box 1050
65836 Sulzbach
Germany
phone: +49 (0)6196 / 5 85 - 1 33
fax: +49 (0)6196 / 5 85 - 4 85
Alexandra Killus
Conference Director
Phone +49 (0)6196 - 5 85 - 2 49
Fax +49 (0)6196 - 5 85 - 2 40
akillus@iir.de
http://www.biotrends.de
Veranstalter: IIR Deutschland GmbH, The Babraham Institute, The BioTOP-Aktionszentrum, CHEManager, CMP Cientifica, The European Nanobusiness Association, The English-language "EUROPEAN BIOTECHNOLOGY Science & Industry News" magazine, Financial Times Deutschland: Economy intelligentyl edited with daily appearance, GoingPublic Media AG - company profile, NanoBioNet, The industry magazine "|transkript",
Wissenschaftliche Leitung: Prof. Dr. Claus-Michael Lehr (Department of Biopharmaceutics and Pharmaceutical Technolgy, Saarland University), Dr. Jörg D. Hoheisel (Division of Functional Genome Analysis, Deutsches Krebsforschungszentrum), Tim Harper (Executive Director, European NanoBusiness Association), Mike Taussig (Head of Technology Research Group, Babraham Institute), Dr. Carlo Effenhauser (Roche Diagnostics Microtechnology Center, Roche Instrument Center AG)
Schlagworte: Biotechnologie